Non-Current Assets

Current tax assets

Pfizer Current tax assets decreased by 9.6% to $3.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.7%, from $2.90B to $3.59B. Over 5 years (FY 2020 to FY 2025), Current tax assets shows an upward trend with a 4.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
Metric ID: non_current_assets_other_tax_assets_current

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$3.76B$3.88B$4.27B$3.12B$2.58B$2.54B$3.58B$3.14B$3.19B$3.92B$3.98B$4.23B$3.69B$3.24B$3.31B$2.90B$4.02B$3.86B$3.97B$3.59B
QoQ Change+3.1%+10.0%-26.9%-17.1%-1.5%+40.6%-12.2%+1.7%+22.6%+1.6%+6.4%-12.7%-12.2%+2.2%-12.5%+38.5%-4.0%+2.9%-9.6%
YoY Change-31.3%-34.4%-16.2%+0.7%+23.7%+54.0%+11.2%+34.8%+15.7%-17.2%-16.7%-31.5%+8.7%+18.9%+19.7%+23.7%
Range$2.54B$4.27B
CAGR-1.0%
Avg YoY Growth+4.0%
Median YoY Growth+10.0%

Frequently Asked Questions

What is Pfizer's current tax assets?
Pfizer (PFE) reported current tax assets of $3.59B in Q1 2026.
How has Pfizer's current tax assets changed year-over-year?
Pfizer's current tax assets increased by 23.7% year-over-year, from $2.90B to $3.59B.
What is the long-term trend for Pfizer's current tax assets?
Over 5 years (2020 to 2025), Pfizer's current tax assets has grown at a 4.0% compound annual growth rate (CAGR), from $3.26B to $3.97B.